financetom
Business
financetom
/
Business
/
JATT II Acquisition Prices $60 Million Initial Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JATT II Acquisition Prices $60 Million Initial Public Offering
Apr 17, 2026 1:23 AM

04:06 AM EDT, 04/17/2026 (MT Newswires) -- JATT II Acquisition (JATT) said late Thursday it priced its initial public offering of 6 million shares at $10 each.

IPO underwriters have a 45-day overallotment option to purchase up to 900,000 additional shares.

The blank-check company expects its shares to begin trading on the Nasdaq Global Market under the ticker symbol JATT Friday, while the IPO is expected to close Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Affiliated Managers Group Shares Fall After Q3 Results Fall Behind Estimates
Update: Affiliated Managers Group Shares Fall After Q3 Results Fall Behind Estimates
Nov 4, 2024
01:35 PM EST, 11/04/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) Affiliated Managers Group ( AMG ) shares fell 9% after the firm's Q3 earnings failed to meet estimates. The company reported Q3 economic earnings of $4.82 per share, up from $4.08 a year earlier. Analysts polled by Capital IQ expected $4.84. Total...
Update: Chemours Shares Jump After Q3 Results Come Ahead of Estimates
Update: Chemours Shares Jump After Q3 Results Come Ahead of Estimates
Nov 4, 2024
01:32 PM EST, 11/04/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) Chemours ( CC ) shares jumped nearly 16% in recent Monday trading after the company's Q3 results came ahead of estimates. The company reported Q3 adjusted earnings of $0.40 per diluted share, down from $0.43 a year earlier. Analysts surveyed by Capital...
Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
Nov 4, 2024
On Monday, Ascendis Pharma A/S ( ASND ) granted Novo Nordisk A/S ( NVO ) an exclusive worldwide license. The pact will focus on the TransCon technology platform to develop, manufacture, and commercialize Novo Nordisk ( NVO ) proprietary products for metabolic diseases (including obesity and type 2 diabetes) and a product-by-product exclusive license for cardiovascular diseases. Also Read: Ascendis...
--Street Color: Uber Plans to Lower Minimum Wage of New York City Drivers, Bloomberg Reports
--Street Color: Uber Plans to Lower Minimum Wage of New York City Drivers, Bloomberg Reports
Nov 4, 2024
01:40 PM EST, 11/04/2024 (MT Newswires) -- Price: 73.67, Change: +0.42, Percent Change: +0.57 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved